Yaz and Yasmin are two of the most popular contraceptives on the market. They use a synthetic progestin called drospirenone which was originally believed to be safer than other types of progestin. However, several studies indicate that this may not be entirely true.
Last year, the FDA issued a warning to Bayer HealthCare, the pharmaceutical company that creates Yaz and Yasmin, claiming the company’s advertising incorrectly depicts the drugs’ effectiveness in treating PMDD (premenstrual dysphoric disorder) and acne, while failing to accurately highlight the risks associated with the drug, including an increased risk of:
- Deep vein thrombosis (blood clots in the deep veins)
- Stroke
- Heart attack
- Gallbladder disease
Currently, Bayer faces more than 1,100 defective drug lawsuits related to safety issues surrounding Yaz and Yasmin. The pharmaceutical company has vigorously defended the safety of these products.
Unfortunately, research regarding the safety of Yaz and Yasmin has been inconclusive. Studies have presented conflicting opinions, making it difficult for women to accurately assess their safety risk. Some studies have indicated Yaz and Yasmin do not pose any greater risk to women’s health than other birth control methods, while other studies claim a substantial increase in risk.
Other studies are currently being conducted, but for now women should consult their doctors about these risks before choosing to use Yaz or Yasmin. It is also a good idea to evaluate several other alternatives to determine if they might be better options.
If you have suffered an injury from taking Yaz or Yasmin, an experienced defective drug lawyer can help you receive the compensation you deserve.
To receive assistance with a Yaz or Yasmin claim, please contact the defective drug lawyers at Schlichter, Bogard & Denton today to schedule your free initial consultation. Schlichter, Bogard Denton serves clients nationwide.
Written by Andrew Martin: professional blogger and guru of misfortune.
